Vanessa Research has appointed Stephen Childs Corporate Controller, effective March 23, 2020. Childs is a graduate of Quinnipiac University and holds a graduate certificate in Accounting from the University of New Haven.
Vanessa Research is a biomedical company founded on the desire to “give hope where none existed” by making an impact on healthcare markets that are often overlooked. The company’s flagship product, Shylicine™, is the first-ever drug developed to treat the rare, lethal microvillus inclusion disease. more